Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Interferon Regulatory Factor-7/metabolism"'
Autor:
Tsiantoulas, Dimitrios, Sage, Andrew P, Göderle, Laura, Ozsvar-Kozma, Maria, Murphy, Deirdre, Porsch, Florentina, Pasterkamp, Gerard, Menche, Jörg, Schneider, Pascal, Mallat, Ziad, Binder, Christoph J
Publikováno v:
Circulation
Circulation, vol. 138, no. 20, pp. 2263-2273
Circulation, vol. 138, no. 20, pp. 2263-2273
Supplemental Digital Content is available in the text.
Background: Atherosclerotic cardiovascular disease (heart attacks and strokes) is the major cause of death globally and is caused by the buildup of a plaque in the arterial wall. Genomic dat
Background: Atherosclerotic cardiovascular disease (heart attacks and strokes) is the major cause of death globally and is caused by the buildup of a plaque in the arterial wall. Genomic dat
Autor:
Dominique Garcin
Publikováno v:
Cell Host & Microbe, Vol. 20, No 6 (2016) pp. 698-700
Viruses have evolved a remarkable array of strategies to escape the host's innate immune responses. In this issue of Cell Host & Microbe, Zhao et al. (2016b) reveal a viral strategy to inactivate RIG-I signaling that relies on deamidation of RIG-I.
Autor:
Christophe Desmet, Matthew L. Albert, Peter Staeheli, Andreas Wack, Sophia Davidson, Matthew R. Buckwalter, Tanel Mahlakõiv, Stefania Crotta
Publikováno v:
PLoS Pathogens
PLoS Pathogens, 2013, 9 (11), pp.e1003773. ⟨10.1371/journal.ppat.1003773⟩
PLoS Pathogens, Public Library of Science, 2013, 9 (11), pp.e1003773. ⟨10.1371/journal.ppat.1003773⟩
PLoS Pathogens, Vol 9, Iss 11, p e1003773 (2013)
PLoS Pathogens, 2013, 9 (11), pp.e1003773. ⟨10.1371/journal.ppat.1003773⟩
PLoS Pathogens, Public Library of Science, 2013, 9 (11), pp.e1003773. ⟨10.1371/journal.ppat.1003773⟩
PLoS Pathogens, Vol 9, Iss 11, p e1003773 (2013)
Interferons (IFNs) are a group of cytokines with a well-established antiviral function. They can be induced by viral infection, are secreted and bind to specific receptors on the same or neighbouring cells to activate the expression of hundreds of IF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0035bb1c07342ebc02c129d14a5a0b91
https://hal-pasteur.archives-ouvertes.fr/pasteur-01402018
https://hal-pasteur.archives-ouvertes.fr/pasteur-01402018
Autor:
Zheng-Yun Xu, Suzanne Paz, Mark J. Cameron, Valérie Janelle, S. Mehdi Belgnaoui, Siddharth Balachandran, Stephanie Richards, Salman T. Qureshi, Marilène Paquet, John Hiscott, Suraj Peri, Khader Ghneim, Elias K. Haddad, Rafick Pierre Sekaly, Peter Wilkinson, Rongtuan Lin, Andrew Smith, Meztli Arguello, Alain Lamarre, Ulrich Kalinke, David Olagnier, Erin I. Lafferty, Marie-Line Goulet
Publikováno v:
Goulet, M-L, Olagnier, D, Xu, Z, Paz, S, Belgnaoui, S M, Lafferty, E I, Janelle, V, Arguello, M, Paquet, M, Ghneim, K, Richards, S, Smith, A, Wilkinson, P, Cameron, M, Kalinke, U, Qureshi, S, Lamarre, A, Haddad, E K, Sekaly, R P, Peri, S, Balachandran, S, Lin, R & Hiscott, J 2013, ' Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity ', P L o S Pathogens, vol. 9, no. 4, pp. e1003298 . https://doi.org/10.1371/journal.ppat.1003298
PLoS Pathogens
PLoS Pathogens, Public Library of Science, 2013, 9 (4), pp.e1003298. ⟨10.1371/journal.ppat.1003298⟩
PLoS Pathogens, Vol 9, Iss 4, p e1003298 (2013)
PLoS Pathogens
PLoS Pathogens, Public Library of Science, 2013, 9 (4), pp.e1003298. ⟨10.1371/journal.ppat.1003298⟩
PLoS Pathogens, Vol 9, Iss 4, p e1003298 (2013)
The RIG-I like receptor pathway is stimulated during RNA virus infection by interaction between cytosolic RIG-I and viral RNA structures that contain short hairpin dsRNA and 5′ triphosphate (5′ppp) terminal structure. In the present study, an RNA
Autor:
Werner Held, Mauro Delorenzi, Curzio Rüegg, Nathalie Duffey, Christine Desmedt, Francois Richard, Qiang Lan, Yu-Ting Huang, Girieca Lorusso, David Barras, Sanam Peyvandi, Christos Sotiriou
Publikováno v:
Oncogene
Oncogene, vol. 38, no. 15, pp. 2814-2829
Oncogene, vol. 38, no. 15, pp. 2814-2829
Neoadjuvant and adjuvant chemotherapies provide survival benefits to breast cancer patients, in particular in estrogen receptor negative (ER-) cancers, by reducing rates of recurrences. It is assumed that the benefits of (neo)adjuvant chemotherapy ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::446e867fdca9c49aae8adeb950afd7f3
https://infoscience.epfl.ch/record/267259
https://infoscience.epfl.ch/record/267259